Goldman Sachs Commodity Index Futures (GSCI)) (GD July 2024)/ XFTTGDCMEGLB / CME GLOBEX
GD2024-06-14 9:56:04 PM | Chg. -0.8000 | Bid11:00:02 PM | Ask11:00:02 PM | Open | High | Low | Previous Close |
---|---|---|---|---|---|---|---|
574.7000USD | -0.14% | - | - | 579.3000 | 579.3000 | 574.7000 | 575.5000 |
GlobeNewswire
06-11
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire
06-05
Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positiv...
GlobeNewswire
06-03
Goliath Mobilizes For 15,000 Meter Drill Program To Test Surebet Feeder Source Plus Three New High-G...
GlobeNewswire
06-03
AMD Extends AI and High-Performance Leadership in Data Center and PCs with New AMD Instinct, Ryzen a...
GlobeNewswire
06-01
Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Gli...
GlobeNewswire
05-31
TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024...
GlobeNewswire
05-30
Genius Metals Completes a High-Resolution MAG Survey on its Dissimieux Phosphate-Titanium-Rare Earth...
GlobeNewswire
05-30
Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and P...
GlobeNewswire
05-28
Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin...
GlobeNewswire
05-28
TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple ...
GlobeNewswire
05-25
Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b OR...
GlobeNewswire
05-21
AMD Instinct MI300X Accelerators Power Microsoft Azure OpenAI Service Workloads and New Azure ND MI3...
GlobeNewswire
05-09
Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
GlobeNewswire
05-01
COMSTOCK RESOURCES, INC. REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATING RESULTS
GlobeNewswire
04-22
GDC Enhances TikTok Marketing for Small and Medium-sized Businesses with Comprehensive Service Suite
GlobeNewswire
04-18
TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple ...
GlobeNewswire
04-17
Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in ...
Newsfile Corp
04-16
Appia Files NI 43-101 Technical Report on Maiden Indicated and Inferred Mineral Resource Estimate fo...
GlobeNewswire
04-16
AMD Expands Commercial AI PC Portfolio to Deliver Leadership Performance Across Professional Mobile ...
GlobeNewswire
04-15
TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis...